Aclaris Therapeutics

Aclaris Therapeutics Advances Immuno-Inflammatory Pipeline, Targets Four Clinical Programs in 2026

WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) reported third-quarter 2025 financial results and outlined continued progress across its expanding immuno-inflammatory pipeline, emphasizing execution in both oral kinase inhibitors and …

Aclaris Therapeutics Advances Immuno-Inflammatory Pipeline, Targets Four Clinical Programs in 2026 Read More



COVID-19 vaccines

Shapiro Administration Reaffirms Vaccine Access, Encourages COVID-19 and Flu Immunization Ahead of Winter

HARRISBURG, PA — As cold and flu season approaches, the Shapiro Administration is ramping up efforts to promote COVID-19 and flu vaccination, emphasizing that shots remain free and widely available …

Shapiro Administration Reaffirms Vaccine Access, Encourages COVID-19 and Flu Immunization Ahead of Winter Read More